Cargando…
Oral Administration of Lipopolysaccharide Enhances Insulin Signaling-Related Factors in the KK/Ay Mouse Model of Type 2 Diabetes Mellitus
Lipopolysaccharide (LPS), an endotoxin, induces systemic inflammation by injection and is thought to be a causative agent of chronic inflammatory diseases, including type 2 diabetes mellitus (T2DM). However, our previous studies found that oral LPS administration does not exacerbate T2DM conditions...
Autores principales: | Yamamoto, Kazushi, Yamashita, Masashi, Oda, Masataka, Tjendana Tjhin, Vindy, Inagawa, Hiroyuki, Soma, Gen-Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003108/ https://www.ncbi.nlm.nih.gov/pubmed/36902049 http://dx.doi.org/10.3390/ijms24054619 |
Ejemplares similares
-
Prevention of Diabetes-Associated Cognitive Dysfunction Through Oral Administration of Lipopolysaccharide Derived From Pantoea agglomerans
por: Mizobuchi, Haruka, et al.
Publicado: (2021) -
Bone marrow transplantation as a strategy for treatment of non-insulin- dependent diabetes mellitus in KK-Ay mice
Publicado: (1992) -
A unique hybrid characteristic having both pro- and anti-inflammatory phenotype transformed by repetitive low-dose lipopolysaccharide in C8-B4 microglia
por: Mizobuchi, Haruka, et al.
Publicado: (2020) -
Nordic Seaweed and Diabetes Prevention: Exploratory Studies in KK-Ay Mice
por: Sørensen, Lasse E., et al.
Publicado: (2019) -
Royal jelly improves hyperglycemia in obese/diabetic KK-Ay
mice
por: YOSHIDA, Mei, et al.
Publicado: (2016)